The set3/Hos2 histone deacetylase complex attenuates camp/pka signaling to regulate morphogenesis and virulence of candida albicans

PLoS Pathogens

Volumn 6, Issue 5, 2010, Pages 1-18

  Hnisz, Denes ^a   Majer, Olivia ^a   Frohner, Ingrid E ^a   Komnenovic, Vukoslav ^b   Kuchler, Karl ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b INSTITUTE OF MOLECULAR BIOTECHNOLOGY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; HISTONE DEACETYLASE; PROTEIN HOS2; PROTEIN SET3; TRICHOSTATIN A; UNCLASSIFIED DRUG; ADENINE; CARBON; DNA BINDING PROTEIN; EFG1 PROTEIN, CANDIDA ALBICANS; FUNGAL PROTEIN; HOS2 PROTEIN, S CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEIN; SET3 PROTEIN, S CEREVISIAE; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; COMPLEX FORMATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; ENZYME ACTIVITY; ENZYME INHIBITION; FUNGAL VIRULENCE; IN VIVO STUDY; MORPHOGENESIS; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECT; ENZYMOLOGY; EPISTASIS; FUNGUS HYPHAE; GENE EXPRESSION REGULATION; GENETICS; HOMOZYGOTE; MALE; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PHENOTYPE; PHYSIOLOGY; SACCHAROMYCES CEREVISIAE; VIRULENCE;

CANDIDA ALBICANS;

ADENINE; ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; CARBON; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DNA-BINDING PROTEINS; EPISTASIS, GENETIC; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; HISTONE DEACETYLASES; HOMOZYGOTE; HYPHAE; MALE; MICE; MICE, INBRED BALB C; PHENOTYPE; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; VIRULENCE;

EID: 77954076396     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000889     Document Type: Article

References (67)

1. Odds FC (1988) Candida and Candidosis: A Review and Bibliography. London: Baillière Tindall.
2. Rooney PJ, Klein BS (2002) Linking fungal morphogenesis with virulence. Cell Microbiol 4: 127-137.
3. Gow NA, Brown AJ, Odds FC (2002) Fungal morphogenesis and host invasion. Curr Opin Microbiol 5: 366-371.
4. Brown AJ, Gow NA (1999) Regulatory networks controlling Candida albicans morphogenesis. Trends Microbiol 7: 333-338.
5. Ernst JF (2000) Transcription factors in Candida albicans - environmental control of morphogenesis. Microbiology 146 (Pt8): 1763-1774.
6. Whiteway M, Bachewich C (2007) Morphogenesis in Candida albicans. Annu Rev Microbiol 61: 529-553.
7. Liu H (2001) Transcriptional control of dimorphism in Candida albicans. Curr Opin Microbiol 4: 728-735.
8. Liu H, Kohler J, Fink GR (1994) Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science 266: 1723-1726.
9. Lo HJ, Kohler JR, DiDomenico B, Loebenberg D, Cacciapuoti A, et al. (1997) Nonfilamentous C. albicans mutants are avirulent. Cell 90: 939-949.
10. Stoldt VR, Sonneborn A, Leuker CE, Ernst JF (1997) Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. Embo J 16: 1982-1991.
11. Braun BR, Johnson AD (1997) Control of filament formation in Candida albicans by the transcriptional repressor TUP1. Science 277: 105-109.
12. Braun BR, Kadosh D, Johnson AD (2001) NRG1, a repressor of filamentous growth in C.albicans, is down-regulated during filament induction. EMBO J 20: 4753-4761.
13. Kadosh D, Johnson AD (2001) Rfg1, a protein related to the Saccharomyces cerevisiae hypoxic regulator Rox1, controls filamentous growth and virulence in Candida albicans. Mol Cell Biol 21: 2496-2505.
14. Murad AM, Leng P, Straffon M, Wishart J, Macaskill S, et al. (2001) NRG1 represses yeast-hypha morphogenesis and hypha-specific gene expression in Candida albicans. EMBO J 20: 4742-4752.
15. Slutsky B, Staebell M, Anderson J, Risen L, Pfaller M, et al. (1987) "Whiteopaque transition": a second high-frequency switching system in Candida albicans. J Bacteriol 169: 189-197.
16. Miller MG, Johnson AD (2002) White-opaque switching in Candida albicans is controlled by mating-type locus homeodomain proteins and allows efficient mating. Cell 110: 293-302.
17. Kvaal C, Lachke SA, Srikantha T, Daniels K, McCoy J, et al. (1999) Misexpression of the opaque-phase-specific gene PEP1 (SAP1) in the white phase of Candida albicans confers increased virulence in a mouse model of cutaneous infection. Infect Immun 67: 6652-6662.
18. Kvaal CA, Srikantha T, Soll DR (1997) Misexpression of the white-phasespecific gene WH11 in the opaque phase of Candida albicans affects switching and virulence. Infect Immun 65: 4468-4475.
19. Hull CM, Johnson AD (1999) Identification of a mating type-like locus in the asexual pathogenic yeast Candida albicans. Science 285: 1271-1275.
20. Huang G, Wang H, Chou S, Nie X, Chen J, et al. (2006) Bistable expression of WOR1, a master regulator of white-opaque switching in Candida albicans. Proc Natl Acad Sci U S A 103: 12813-12818.
21. Zordan RE, Galgoczy DJ, Johnson AD (2006) Epigenetic properties of whiteopaque switching in Candida albicans are based on a self-sustaining transcriptional feedback loop. Proc Natl Acad Sci U S A 103: 12807-12812.
22. Zordan RE, Miller MG, Galgoczy DJ, Tuch BB, Johnson AD (2007) Interlocking transcriptional feedback loops control white-opaque switching in Candida albicans. PLoS Biol 5: e256.
23. Sonneborn A, Tebarth B, Ernst JF (1999) Control of white-opaque phenotypic switching in Candida albicans by the Efg1p morphogenetic regulator. Infect Immun 67: 4655-4660.
24. Srikantha T, Tsai LK, Daniels K, Soll DR (2000) EFG1 null mutants of Candida albicans switch but cannot express the complete phenotype of white-phase budding cells. J Bacteriol 182: 1580-1591.
25. Hnisz D, Schwarzmuller T, Kuchler K (2009) Transcriptional loops meet chromatin: a dual-layer network controls white-opaque switching in Candida albicans. Mol Microbiol 74: 1-15.
26. Pijnappel WW, Schaft D, Roguev A, Shevchenko A, Tekotte H, et al. (2001) The S. cerevisiae SET3 complex includes two histone deacetylases, Hos2 and Hst1, and is a meiotic-specific repressor of the sporulation gene program. Genes Dev 15: 2991-3004.
27. Mou Z, Kenny AE, Curcio MJ (2006) Hos2 and Set3 promote integration of Ty1 retrotransposons at tRNA genes in Saccharomyces cerevisiae. Genetics 172: 2157-2167.
28. Cohen TJ, Mallory MJ, Strich R, Yao TP (2008) Hos2p/Set3p deacetylase complex signals secretory stress through the Mpk1p cell integrity pathway. Eukaryot Cell 7: 1191-1199.
29. Sudbery P, Gow N, Berman J (2004) The distinct morphogenic states of Candida albicans. Trends Microbiol 12: 317-324.
30. Birse CE, Irwin MY, Fonzi WA, Sypherd PS (1993) Cloning and characterization of ECE1, a gene expressed in association with cell elongation of the dimorphic pathogen Candida albicans. Infect Immun 61: 3648-3655.
31. Uhl MA, Biery M, Craig N, Johnson AD (2003) Haploinsufficiency-based largescale forward genetic analysis of filamentous growth in the diploid human fungal pathogen C.albicans. EMBO J 22: 2668-2678.
32. Yoshida M, Kijima M, Akita M, Beppu T (1990) Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 265: 17174-17179.
33. Hwang CS, Oh JH, Huh WK, Yim HS, Kang SO (2003) Ssn6, an important factor of morphological conversion and virulence in Candida albicans. Mol Microbiol 47: 1029-1043.
34. Tebarth B, Doedt T, Krishnamurthy S, Weide M, Monterola F, et al. (2003) Adaptation of the Efg1p morphogenetic pathway in Candida albicans by negative autoregulation and PKA-dependent repression of the EFG1 gene. J Mol Biol 329: 949-962.
35. Raman SB, Nguyen MH, Zhang Z, Cheng S, Jia HY, et al. (2006) Candida albicans SET1 encodes a histone 3 lysine 4 methyltransferase that contributes to the pathogenesis of invasive candidiasis. Mol Microbiol 60: 697-709.
36. Watson AD, Edmondson DG, Bone JR, Mukai Y, Yu Y, et al. (2000) Ssn6-Tup1 interacts with class I histone deacetylases required for repression. Genes Dev 14: 2737-2744.
37. Sharkey LL, McNemar MD, Saporito-Irwin SM, Sypherd PS, Fonzi WA (1999) HWP1 functions in the morphological development of Candida albicans downstream of EFG1, TUP1, and RBF1. J Bacteriol 181: 5273-5279.
38. Braun BR, Johnson AD (2000) TUP1, CPH1 and EFG1 make independent contributions to filamentation in Candida albicans. Genetics 155: 57-67.
39. Braun BR, Head WS, Wang MX, Johnson AD (2000) Identification and characterization of TUP1-regulated genes in Candida albicans. Genetics 156: 31-44.
40. Martchenko M, Alarco AM, Harcus D, Whiteway M (2004) Superoxide dismutases in Candida albicans: transcriptional regulation and functional characterization of the hyphal-induced SOD5 gene. Mol Biol Cell 15: 456-467.
41. Kaiser C, Michaelis S, Mitchell A (1994) Methods in Yeast Genetics. A Laboratory Course Manual. New York: Cold Spring Harbor Laboratory Press.
42. Biswas S, Van Dijck P, Datta A (2007) Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. Microbiol Mol Biol Rev 71: 348-376.
43. Kumamoto CA (2005) A contact-activated kinase signals Candida albicans invasive growth and biofilm development. Proc Natl Acad Sci U S A 102: 5576-5581.
44. Thevelein JM, de Winde JH (1999) Novel sensing mechanisms and targets for the cAMP-protein kinase A pathway in the yeast Saccharomyces cerevisiae. Mol Microbiol 33: 904-918.
45. Uno I, Matsumoto K, Adachi K, Ishikawa T (1983) Genetic and biochemical evidence that trehalase is a substrate of cAMP-dependent protein kinase in yeast. J Biol Chem 258: 10867-10872.
46. Castilla R, Passeron S, Cantore ML (1998) N-acetyl-D-glucosamine induces germination in Candida albicans through a mechanism sensitive to inhibitors of cAMP dependent protein kinase. Cell Signal 10: 713-719.
47. Bockmuhl DP, Krishnamurthy S, Gerads M, Sonneborn A, Ernst JF (2001) Distinct and redundant roles of the two protein kinase A isoforms Tpk1p and Tpk2p in morphogenesis and growth of Candida albicans. Mol Microbiol 42: 1243-1257.
48. Bedell GW, Soll DR (1979) Effects of low concentrations of zinc on the growth and dimorphism of Candida albicans: evidence for zinc-resistant and -sensitive pathways for mycelium formation. Infect Immun 26: 348-354.
49. Carlisle PL, Banerjee M, Lazzell A, Monteagudo C, Lopez-Ribot JL, et al. (2009) Expression levels of a filament-specific transcriptional regulator are sufficient to determine Candida albicans morphology and virulence. Proc Natl Acad Sci U S A 106: 599-604.
50. Lu Y, Su C, Mao X, Raniga PP, Liu H, et al. (2008) Efg1-mediated recruitment of NuA4 to promoters is required for hypha-specific Swi/Snf binding and activation in Candida albicans. Mol Biol Cell 19: 4260-4272.
51. Kim T, Buratowski S (2009) Dimethylation of H3K4 by Set1 recruits the Set3 histone deacetylase complex to 59 transcribed regions. Cell 137: 259-272.
52. Xu XL, Lee RT, Fang HM, Wang YM, Li R, et al. (2008) Bacterial peptidoglycan triggers Candida albicans hyphal growth by directly activating the adenylyl cyclase Cyr1p. Cell Host Microbe 4: 28-39.
53. Domergue R, Castano I, De Las Penas A, Zupancic M, Lockatell V, et al. (2005) Nicotinic acid limitation regulates silencing of Candida adhesins during UTI. Science 308: 866-870.
54. Zheng X, Wang Y (2004) Hgc1, a novel hypha-specific G1 cyclin-related protein regulates Candida albicans hyphal morphogenesis. EMBO J 23: 1845-1856.
55. Saville SP, Lazzell AL, Monteagudo C, Lopez-Ribot JL (2003) Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell 2: 1053-1060.
56. Hull CM, Heitman J (2002) Genetics of Cryptococcus neoformans. Annu Rev Genet 36: 557-615.
57. Simonetti G, Passariello C, Rotili D, Mai A, Garaci E, et al. (2007) Histone deacetylase inhibitors may reduce pathogenicity and virulence in Candida albicans. FEMS Yeast Res 7: 1371-1380.
58. Smith WL, Edlind TD (2002) Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation. Antimicrob Agents Chemother 46: 3532-3539.
59. Turner B, Murch L (2009) Interscience Conference on Antimicrobial Agents and Chemotherapy-49th annual meeting. Part 1. 11-15 September 2009, San Francisco, CA, USA. IDrugs 12: 667-669.
60. Guenther MG, Lane WS, Fischle W, Verdin E, Lazar MA, et al. (2000) A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness. Genes Dev 14: 1048-1057.
61. Liu OW, Chun CD, Chow ED, Chen C, Madhani HD, et al. (2008) Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans. Cell 135: 174-188.
62. Noble SM, Johnson AD (2005) Strains and strategies for large-scale gene deletion studies of the diploid human fungal pathogen Candida albicans. Eukaryot Cell 4: 298-309.
63. Gillum AM, Tsay EY, Kirsch DR (1984) Isolation of the Candida albicans gene for orotidine-59-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 198: 179-182.
64. Reuss O, Vik A, Kolter R, Morschhauser J (2004) The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. Gene 341: 119-127.
65. Goldstein AL, McCusker JH (1999) Three new dominant drug resistance cassettes for gene disruption in Saccharomyces cerevisiae. Yeast 15: 1541-1553.
66. Cassola A, Parrot M, Silberstein S, Magee BB, Passeron S, et al. (2004) Candida albicans lacking the gene encoding the regulatory subunit of protein kinase A displays a defect in hyphal formation and an altered localization of the catalytic subunit. Eukaryot Cell 3: 190-199.
67. Roman E, Nombela C, Pla J (2005) The Sho1 adaptor protein links oxidative stress to morphogenesis and cell wall biosynthesis in the fungal pathogen Candida albicans. Mol Cell Biol 25: 10611-10627.